Key Highlights

● Net revenue was about 238 million Canadian dollars, down roughly 2.5% from a year earlier.

● A non-cash goodwill impairment of about 52 million Canadian dollars deepened the quarterly loss.

● Record free cash flow near 20 million Canadian dollars included a one-time 10.5 million benefit.

● SNDL launched a strategic review of Cannabis Operations and reported no outstanding debt.

SNDL (NASDAQ:SNDL) moved back into the spotlight on Tuesday, October 27, when the Calgary-based company released its third quarter results before the market opened. The report covered the three months ended September 30 and offered a mixed picture: cleaner underlying operating earnings and a record quarter for free cash flow, set against a large non-cash goodwill charge that pushed the bottom line deeper into the red.

The numbers matter because SNDL is an unusual hybrid among cannabis names. It runs the largest private-sector liquor and cannabis retail network in Canada, operates a cannabis production arm, and carries a sizeable portfolio of stakes in other cannabis businesses, including a large position in the U.S.-focused SunStream platform. The quarter showed those pieces moving in different directions, and management responded by opening a strategic review of the production unit and announcing a workforce reduction at its Kelowna facility.

All figures are in Canadian dollars unless stated otherwise and come from the company's release.

What did SNDL report for the third quarter of 2026?

According to the company's earnings release, SNDL generated net revenue of about $238 million in the third quarter, a decline of roughly 2.5% from the same period a year earlier. Gross margin dollars came to about $58 million, down nearly 10%, and the gross margin percentage slipped about two points to roughly 24%.

The operating line told a harsher story on a reported basis. SNDL recorded an operating loss of about $48 million, which includes a non-cash goodwill impairment of about $52 million tied to Cannabis Operations. Strip out that charge and other adjustments, and the company reported adjusted operating earnings of about $5 million, compared with an adjusted loss of roughly $9.5 million a year earlier. That swing is the improvement management pointed to when it spoke about better underlying financial performance.

Adjusted EBITDA, a measure that removes depreciation, interest, taxes and certain one-time items, was about $16 million versus about $18 million a year earlier. The net loss widened to about $51 million from about $13 million. Because the goodwill charge is non-cash, it does not directly reduce the cash the company has on hand, but it does signal that management now values the production arm's acquired assets below their prior carrying amount.

How did SNDL's liquor and cannabis retail businesses perform?

Retail remains the backbone of SNDL's revenue. Liquor Retail generated about $135 million, down about 3%, with same-store sales falling about 6%. Even so, the segment posted a record gross margin of roughly 27% and operating earnings of about $6 million, which points to pricing, product mix and cost control offset softer foot traffic.

Cannabis Retail, which includes the Spiritleaf and Value Buds banners, delivered a record quarter of its own. Revenue edged up to about $86 million, a gain of under 1%, and gross margin also reached a record near 27%. Same-store sales declined by about 4%, so the revenue gain reflects store count and mix more than stronger traffic at existing locations. The segment produced operating earnings of about $5 million.

As of October 26, the company counted 165 liquor locations and 193 cannabis locations. Together the two retail segments contributed roughly nine-tenths of consolidated net revenue. That concentration is useful context for the rest of the report: whatever happens inside the production arm, the consolidated top line is driven mainly by shelves, not by greenhouses.

Why is SNDL reviewing its Cannabis Operations segment?

Cannabis Operations was the weak spot of the quarter. Revenue fell by about 28% to roughly $27 million, gross margin was negative at about 6%, and the segment recorded an operating loss of about $65 million, most of it attributable to the goodwill impairment. For a business unit that supplies flower and other products to provincial wholesalers and other licensed channels, a negative gross margin means the cost of growing, processing and packaging exceeded sales revenue in the period.

In response, SNDL said it has launched a strategic review of the unit and announced a workforce reduction of more than 30% at its Kelowna facility. The company did not frame the review as a decision to exit or divest; a strategic review typically means management is examining options that can include restructuring, partnerships, consolidation of sites or divestiture. No outcome or timetable was included in the release.

The decision follows a long period in which Canadian licensed producers have faced price compression, an oversupplied wholesale market and competition from illicit and unregulated suppliers. SNDL's retail arm gives it a view of end-consumer demand that pure producers lack, and that visibility may inform what the review concludes. For now, the challenge is plain in the numbers: shrinking wholesale revenue and a cost base that has not yet adjusted.

What does SNDL's record free cash flow actually include?

The company reported free cash flow of about $20 million for the quarter, which it described as a quarterly record. Free cash flow is operating cash generation minus capital spending, and it is often watched in the cannabis group because many peers still burn cash. SNDL's figure deserves context, however: it included a benefit of about $10.5 million from unwinding a captive insurance arrangement. Excluding that item, free cash flow would have been closer to $9.5 million, still positive but roughly half the headline.

Total cash and cash equivalents ended the period at about $132.5 million, and the company recorded a change in cash of negative $51 million during the quarter. The decline reflects about $61 million of strategic stakes in U.S. cannabis-related assets and about $10 million spent on the share retirement program, which together exceeded the cash the business generated.

The pattern matters for how the balance sheet is read. SNDL is generating modest operating cash, but it is also moving money from cash into longer-dated stakes. Cash on hand therefore tells only part of the story, and the broader pool of unrestricted cash, marketable securities and equity stakes is the more complete measure. That pool stood at about $618 million at quarter end.

How large is SNDL's balance sheet and how does the SunStream stake fit in?

SNDL reported no outstanding debt at the end of the quarter and stock owners' equity of about $1 billion. Its cannabis-related stakes, which the company carries at roughly $485 million, include a SunStream position valued at about $468 million. The company noted that equity-accounted affiliates, mainly SunStream, contributed about $7 million of operating earnings in the quarter within its stake-based segment, which reported about $8 million in total.

This structure is why SNDL is often discussed differently from its Canadian peers. Rather than relying solely on cannabis sales, it has built a book of stakes in businesses that could benefit if American federal rules change. Those positions, however, are carried at values that depend on assumptions about the operators' performance, and they are not easily converted into cash in a short period.

A development during the period illustrates this. The restructuring of Parallel, formerly known as Surterra, closed in July and reduced that company's debt by about 842 million U.S. dollars. A rights offering lifted SNDL's indirect equity ownership in Parallel from about two-thirds to roughly 92%. A larger ownership share brings more exposure to Parallel's results, in either direction, and raises questions about how much further cash the company may deploy into U.S. assets in coming quarters.

What is the SNDL share retirement program and what is the issuer bid under review?

During the third quarter SNDL retired about 5.5 million shares spending about $10 million. Year to date through October 22, the company retired about 23 million shares, and shares outstanding stood at roughly 243 million.

The company also said a possible substantial issuer bid is being weighed, in an amount of up to $50 million at a price no higher than $1.92 per share. A substantial issuer bid is a formal Canadian tender offer by which a company invites stock owners to offer shares back at a stated price or range. The release characterized it as a possibility, not a decision, so no terms are final and a launch is not assured.

Share retirement lowers the count of shares outstanding and can lift per-share measures when earnings are positive, but it also uses cash that could otherwise fund acquisitions, restructuring or the U.S. stakes noted above. Management has had to balance those uses at the same time that the production arm is losing money, which is one reason the quarter drew attention.

What regulatory matter involving SNDL and Ontario's AGCO is nearing resolution?

The release also referred to Ontario regulatory matters involving the Alcohol and Gaming Commission of Ontario, known as the AGCO, which oversees cannabis retail licensing in the province. The company said these matters are expected to be resolved, subject to final documentation, with a penalty of 200,000 Canadian dollars.

The amount is small relative to SNDL's revenue and balance sheet, so the financial effect appears limited. The significance is more procedural: Ontario is the largest provincial cannabis retail market in Canada, and retailers operating there are subject to rules on store licensing, ownership structures and compliance reporting. Closing out an open regulatory file removes one uncertainty from the retail story, although the release did not describe the underlying allegations in detail.

How do SNDL's segments compare with each other in the quarter?

Laying the segments side by side shows how uneven the quarter was. Liquor Retail produced about $6 million of operating earnings and Cannabis Retail about $5 million. The stake-based segment contributed about $8 million. Corporate costs were an operating loss of roughly $3 million. Against those positives, Cannabis Operations lost about $65 million, of which the goodwill charge was about $52 million, leaving a roughly $13 million operating loss on an underlying basis.

That arithmetic explains why the adjusted operating earnings figure improved even though the reported loss widened. Excluding impairment, the retail arms and the stake-based segment more than covered the production loss and corporate costs. It also shows how dependent the consolidated result is on non-retail items, since equity-accounted earnings are not cash that flows into the business each quarter.

For market participants following the stock, the practical question is how much of the retail strength is durable. Same-store sales declined in both retail segments, which means margin gains rather than volume growth drove the record gross margin figures. Margins can improve through supplier terms and mix, but they have natural ceilings, and falling store traffic would eventually weigh on absolute gross margin dollars.

How does SNDL compare with other Canadian cannabis producers right now?

The broader group has been working through its own restructuring of how it makes money. Aurora Cannabis (NASDAQ:ACB) has refocused on global medical cannabis, Canopy Growth (NASDAQ:CGC) has completed an acquisition of a medical producer in Canada and is trying to reach positive adjusted EBITDA, and Tilray Brands (NASDAQ:TLRY) has leaned on beverages and distribution. SNDL stands apart because retail is its largest earnings contributor and because it carries large stakes in American operators.

That positioning cuts both ways. Retail is more stable than wholesale growing, and the record gross margins show it. But retail is also exposed to the pricing and store-count dynamics of provinces such as Alberta and Ontario, and to competition from other licensed retailers. The production arm, meanwhile, faces the same wholesale pricing pressures as peers without the benefit of the high-priced international medical channel that some competitors have built.

The strategic review could narrow that gap in either direction. If it results in a leaner production footprint, consolidated margins may benefit; if it results in additional charges, reported losses could remain elevated. The company has not said which path is likely, and the figures in the release do not allow for a firm conclusion.

What should market participants watch after the SNDL results?

Several dated and undated items are worth tracking. The first is the outcome of the Cannabis Operations review and any further charges or workforce changes beyond the Kelowna reduction. The second is whether the substantial issuer bid moves from possibility to formal launch, and at what terms. The third is how the company allocates cash between the share retirement program and additional U.S. stakes, given that the quarter's cash decline was driven by both.

A fourth item is the pace of same-store sales. Both retail segments reported declines, and the record margins cannot offset a lengthy period of falling traffic indefinitely. A fifth is the progress of the Parallel restructuring now that SNDL's indirect stake is much larger, including how that business performs without its prior debt load.

Finally, cash flow quality will be examined. The record free cash flow figure included a one-time benefit, so the next few quarters will show whether the underlying level near $9.5 million is sustainable.